Nutraq as · 99-39 · NORWAY
For Nutraq as · 99-39 · NORWAY, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is NORWAY; product is ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan; product code is 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 05/05/2015; address is Enebakkveien 117 , Oslo, NO-03 NORWAY, verified against its source on 2026-09-16.
- Firm
- Nutraq as verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- NORWAY verified
- Address
- Enebakkveien 117 , Oslo, NO-03 NORWAY verified
- Date published
- 05/05/2015 verified
- Product code
- 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. each item verified
- Product
- ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan each item verified
- FDA notes
- The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 each item verified
What the source says
Nutraq as Date Published : 05/05/2015 Enebakkveien 117 , Oslo, NO-03 NORWAY 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 46 Y - - 99 Food Additives For Human Use, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 46 Y - - 99 Food Additives For Human Use, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 A - - 99 Vitamin, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 A - - 99 Vitamin, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.